Tanacetum
parthenium is
the plant commonly referred to as
feverfew or chrysanthemum. It is a
member of the Asteraceae or daisy
family. [1] Botanically, the plant appears as a
short, bushy perennial, with
yellow-green leaves and yellow
flowers that look similar to the
flowers of chamomile. [2]
The leaves are used medicinally, and
it has been said that preparations
of feverfew taste bitter, aromatic,
and slightly sweet. Feverfew
originated in Europe and the Balkan
Peninsula, and is also reported to have grown
around the Greek Parthenon, hence
its name. [3]
Feverfew's popularity
resulted from an article published
in Prevention magazine in 1978.
The article highlighted a woman,
Anne Jenkins, whom for years has used the plant
to treat her migraine headaches.[4]
She was an advocate
and strong proponent for the medicinal use of feverfew.
Her passion, along with that of many
others, resulted in the Migraine
Trust of the United Kingdom to begin
research on feverfew's medicinal
relevance..
There are a number of
compounds in feverfew responsible
for its medicinal activity. Volatile
oils make up a vital component, with
the most significant oils being L-camphor and
trans-chrysanthylacetate. Other
volatile oils include camphene,
p-cymene, linalool, borneol,
and terpenes-4-ol. Feverfew also
contains sesquiterpene lactones
(mostly parthenolide), flavonoids,
and polyenes. [5]
The sesquiterpene
lactone, parthenolide, appears to
play a significant role in the
pharmacology of this plant in
relation to pain; more specifically, migraine headaches. Parthenolide
accounts for nearly 85% of the sesquiterpene lactone
content found in feverfew. [6] This compound possesses
anti-platelet activity which
prevents platelets from aggregating
or sticking together. [7] It also inhibits the release of
serotonin and other chemical
mediators of inflammation from platelets. This is important for
migraine headache sufferers, as such attacks are thought to be
triggered by a significant increase
in serotonin caused by platelets. Furthermore, feverfew also interacts
with the protein kinase C pathway, which may
also be responsible for the
anti-migraine activity of this
plant.
Regarded by most as
mainly an anti-migraine herb,
feverfew possesses a number of
medicinal actions, including:
-
diaphoretic (increases
perspiration)
-
anti-inflammatory*
-
emmenogogue (promotes menstruation)
-
anti-helmintic (destroys parasites)
-
bitter
-
anti-histamine
-
decreases
platelet aggregation
-
serotonin
release
Traditionally,
feverfew has been used by herbalists
to treat conditions of the
gastrointestinal tract (e.g. parasitic worms), as an immune
stimulant, for various gynecologic
conditions, and in the treatment of
renal (kidney) disorders. [8,
9]
Feverfew was also included in
miscellaneous topical applications,
used to
address musculoskeletal conditions
like sprains and rheumatic
disorders.
*The anti-inflammatory
activity results from the inhibition of
chemical inflammatory mediators
including prostaglandins, leukotrienes, and thromboxanes.
The bulk of
scientific research on feverfew has
focused on the treatment of migraine
headaches. An initial survey
conducted by a migraine specialist,
Dr. Stewart Johnson, concluded that
72% of patients indicated that feverfew
helped prevent their migraine
attacks; 78% of this percentage of patients
suffering from
tension headaches found feverfew
to decrease the frequency and severity
of attacks; 33% of which noticed complete
disappearance of attacks. [10] Other significant findings included
reductions in associated nausea and
vomiting, lower proportion of
patients with aura, improved
response to conventional pain
medications, relief of arthritis
symptoms and no noted interactions
with prescription medications. Side
effects were minimal. Some subjects
experienced improved digestive
function, sleep, and an overall sense of
well-being.
Double-blind, placebo-controlled studies have supported
the results of this initial survey. One such study was conducted with
migraine patients who had been
effectively self-medicating with raw
feverfew every day for 3 months. [11,
12] These
subjects were given 25 milligrams
(mg) of a
freeze-dried leaf preparation or
placebo, for six 4 week periods. The
results showed that the patients who
received the placebo had a
significant re-emergence of migraine
attacks, with associated nausea and
vomiting.
Another clinical trial was
carried out in patients with classic
or common migraine. [13]
These patients were given powdered
freeze-dried capsules of feverfew,
containing 2.2μmol parthenolide, or
placebo for 4 months. They
were then switched
over to the other treatment
protocols for
another 4 month period. Again, the results
demonstrated that treatment with
feverfew significantly reduced the
mean number of attacks and
associated vomiting. No
adverse effects were noted.
Feverfew has
demonstrated significant anti-microbial activity,
as observed with in vitro experiments. Antibacterial activity against
Staphylococcus aureus, Escherichia
coli, and Salmonella spp.
has been documented using a
particular category of constituents,
namely, eudesmanolides. [14]
The volatile oil component also was
shown to effectively inhibit the bactericidal and
fungicidal activity of some 27
microorganisms tested. [15]
Based on its
extensively studied
anti-inflammatory activity, feverfew
could also be used to treat conditions
associated with inflammation. Although, one double-blind, placebo-controlled clinical trial conducted
in patients with rheumatoid
arthritis did not demonstrate any
benefit in the groups taking
feverfew, further trials need be
carried out; to examine other
inflammatory conditions, dosage
levels, and treatment durations. [16]
Other conditions for
which feverfew may be useful include; relieving dysmenorrheal (menstrual
cramps), hyperlipidemia,
bronchoconstrictive disorders,
psoriasis, facilitation of the third
stage of labor, and fever reduction. [17-19]
Extracts of feverfew
are generally standardized to
contain a particular amount of parthenolide content. The Health
Protection Branch of the Health and
Welfare Department of Canada
mandates that preparations contain
0.2% of this constituent. For the
treatment of migraine headaches, a
typical dose would be 250 milligrams
of parthenolide daily. [3]
If using dried leaf, it should
contain 0.2% parthenolide, as
mentioned, administered in dosages
of 125 milligrams
daily. Treatments should be
continued for a minimum duration of at least 4 - 6
weeks, to accurately assess the
effect of applied dosages.
Treatment times will
vary among patients, and then must be
continued as prophylaxis. Clinical
studies have shown that it may take
in excess of 4 - 6 months to
accurately assess
efficacy. [20]
|
Feverfew Toxicities and
Contraindications |
Feverfew is
contraindicated in pregnancy due to
its potential emmenagogue effect,
and also in nursing mothers. It
should never be administered to children
under the age of 2. If taking
prescription medications for
migraines, feverfew treatment should
be discussed with a physician. [3]
Feverfew may cause
contact dermatitis and ulceration of
the mucous membranes, if chewing the
leaves. [21] This usually does not occur with
capsule and tincture preparations. Minor gastrointestinal upset and
nervousness may also occur. Long-term toxicity studies have not
been conducted. Extreme overdose may
induce a coma and possibly death
through respiratory failure. [4]
The following table lists various
products that contain a safe and
reliable source of Feverfew:
|
Manufacturer |
Ingredient |
Amount |
US RDA |
Learn More |
|
GNC |
Feverfew |
500mg |
-- |
Click Here
 |
|
Natures Way |
Feverfew |
380mg |
-- |
Click Here
 |